These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 36618348)
1. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma. Xu F; Yan J; Peng Z; Liu J; Li Z Front Immunol; 2022; 13():1096009. PubMed ID: 36618348 [TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. Liu J; Lu J; Li W Front Immunol; 2021; 12():738068. PubMed ID: 34630418 [TBL] [Abstract][Full Text] [Related]
3. Identification and Development of an Age-Related Classification and Signature to Predict Prognosis and Immune Landscape in Osteosarcoma. Hong J; Wang X; Yu L; Li J; Hu H; Mao W J Oncol; 2022; 2022():5040458. PubMed ID: 36276293 [TBL] [Abstract][Full Text] [Related]
4. Identification of an EMT-related gene-based prognostic signature in osteosarcoma. Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261 [TBL] [Abstract][Full Text] [Related]
5. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy. Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X Front Immunol; 2022; 13():1017120. PubMed ID: 36189307 [TBL] [Abstract][Full Text] [Related]
6. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma. He L; Yang H; Huang J BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis. Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H Front Immunol; 2022; 13():997765. PubMed ID: 36275664 [TBL] [Abstract][Full Text] [Related]
8. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma. Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858 [TBL] [Abstract][Full Text] [Related]
9. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma. Hong X; Fu R PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294 [TBL] [Abstract][Full Text] [Related]
10. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma. Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752 [TBL] [Abstract][Full Text] [Related]
11. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
12. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction. Xie L; Zeng J; He M BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224 [TBL] [Abstract][Full Text] [Related]
13. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma. Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J Front Immunol; 2022; 13():1028263. PubMed ID: 36275679 [TBL] [Abstract][Full Text] [Related]
14. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma. Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155 [TBL] [Abstract][Full Text] [Related]
15. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer. Liu ZY; Xin L Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804 [TBL] [Abstract][Full Text] [Related]
16. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction. Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J Front Immunol; 2023; 14():1265098. PubMed ID: 38169731 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma. Wu ZY; Shi ZY Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients. Lin Y; Tang H; Teng H; Feng W; Li F; Liu S; Liu Y; Wei Q Int Immunopharmacol; 2024 Jan; 127():111364. PubMed ID: 38101221 [TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma. Feng J; Wang J; Xu Y; Lu F; Zhang J; Han X; Zhang C; Wang G PLoS One; 2023; 18(7):e0288180. PubMed ID: 37405988 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients. Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]